Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000383967 | SCV000426374 | likely benign | Pulmonary hypertension, primary, 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Invitae | RCV001516961 | SCV001725339 | benign | Primary pulmonary hypertension | 2023-04-14 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001812872 | SCV002050011 | benign | not provided | 2023-06-28 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV002248619 | SCV002518157 | benign | not specified | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002502289 | SCV002797234 | benign | Pulmonary hypertension, primary, 1; Pulmonary venoocclusive disease 1 | 2022-04-14 | criteria provided, single submitter | clinical testing | |
Rare Disease Genomics Group, |
RCV001516961 | SCV000575939 | benign | Primary pulmonary hypertension | 2024-02-07 | no assertion criteria provided | literature only | The NM_001204.7(BMPR2):c.-669G>A variant has an allele frequency of >2% in the European (Finnish) population and has been observed in the homozygous state (n=24) in the gnomAD database (v.4.0.0). Therefore, this variant meets our criteria to be classified as benign, based on allele frequency data. |